48,830
edits
Difference between revisions of "Uterine cervix"
Jump to navigation
Jump to search
m
→IHC
m (→IHC) |
|||
| Line 125: | Line 125: | ||
Features:<ref name=pmid12819393>{{Cite journal | last1 = Qiu | first1 = W. | last2 = Mittal | first2 = K. | title = Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium. | journal = Int J Gynecol Pathol | volume = 22 | issue = 3 | pages = 261-5 | month = Jul | year = 2003 | doi = 10.1097/01.PGP.0000071043.12278.8D | PMID = 12819393 }}</ref> | Features:<ref name=pmid12819393>{{Cite journal | last1 = Qiu | first1 = W. | last2 = Mittal | first2 = K. | title = Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium. | journal = Int J Gynecol Pathol | volume = 22 | issue = 3 | pages = 261-5 | month = Jul | year = 2003 | doi = 10.1097/01.PGP.0000071043.12278.8D | PMID = 12819393 }}</ref> | ||
*Ki-67 ~ 0.5% cells. | *Ki-67 ~ 0.5% cells. | ||
*Vimentin -ve. | |||
*PR +ve ~ 60% of cases. | *PR +ve ~ 60% of cases. | ||
*ER +ve/-ve. | *ER +ve/-ve. | ||